Amgen (AMGN)
$310.88
1.50 (0.48%)
AMGN Stock Quote Delayed 30 Minutes
Amgen, Inc. (AMGN) Beats Q1 Estimates, Posts Weak F18 Guidance
Amgen (AMGN) had a mixed quarterly earnings report as the company topped analysts' earnings expectations, but its full-year outlook missed the mark.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
1.27M
Day's Range
$308.57 - $313.41
52-Week Range
$218.61 - $329.72
Dividend & Yield
$8.52 (2.74%)
AMGN Stock Predictions, Articles, and Amgen News
The Amgen, Inc. Stock Spring Is About to Pop
Amgen stock is coiling like a spring. When the breakout comes, use AMGN call spreads to profit.
Sell for Amgen (AMGN) This Week
Amgen (AMGN) remains a Sell this week based on the latest market intelligence, and comparative pricing of its shares.
Wednesday’s Vital Data: Alibaba Group Holding Ltd (BABA), Amgen Inc. (AMGN) and Advanced Micro Devices, Inc. (AMD)
Alibaba (BABA) options jump on Baozun earnings, Amgen (AMGN) volume spikes ahead of FDA review and Advanced Micro (AMD) puts continue to pile up.
Sell for Amgen (AMGN) This Week
The Sell for Amgen (AMGN) this week is based on the most current comparative pricing of its shares and stock market rankings.
Sell for Amgen (AMGN) This Week
The Sell for Amgen (AMGN) this week is based on the most current relative pricing of its shares and stock market ratings.
At $182.68, Amgen (AMGN) a Sell
Amgen (AMGN) a Sell this week based on the most current stock market ratings, and comparative pricing of its shares.
This week, Amgen (AMGN) a Sell
At $183.57, Amgen (AMGN) a Sell based on the most recent comparative pricing of its shares and market intelligence.
Trade of the Day: Amgen, Inc. Remains a Promising Biotechnology Play
AMGN stock remains in a technically sound position and offers investors and traders well-defined risk, particularly after the two-week sell-off.
An Earnings Miss Ushers in an Era of Stagnation for Amgen, Inc. Stock
Amgen stock fell in after-hours trading as a rare quarterly and annual earnings and revenue miss had investors selling AMGN stock. Investors should pass on AMGN stock.
3 Stocks to Watch on Friday: Amgen, Inc. (AMGN), Edwards Lifesciences Corp (EW) and Motorola Solutions Inc (MSI)
Amgen (AMGN) posted underwhelming earnings, Edwards Lifesciences (EW) posts strong 2017 revenue and Motorola Solutions (MSI) expects 2018 EPS to beat estimates.
5 Biotech and Pharmaceutical Stocks Going Bonkers
These biotech and pharmaceutical stocks are soaring insanely high right now. Here's what investors should know about each of these hot stocks to buy.
Best ETFs for 2018: Break Through With the ALPS Medical Breakthroughs ETF
Trying to pick just the right biotech stock to invest in? The ALPS Medical Breakthroughs ETF (SBIO) eases that burden.
Feeble Industry Group Rank Hamper Amgen (AMGN) Rating
Currently, Amgen Inc (NASDAQ:AMGN) has a Hold using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing methodology. The current Portfolio Grader recommendation on the shares has been in place for 3 months.
Industry Group Rank Limit Amgen (AMGN) Rating
Amgen Inc (NASDAQ:AMGN) ranks in the top 10% of its industry group, Biotechnology, and in the top decile of sector group, Health Care, with a market value of $128.8 billion. From an investment attractiveness viewpoint, AMGN is ranked in the top half of the sector with a ranking of 344 among the 782 companies in the sector; Portfolio Grader's current ranking for AMGN puts it 143 among the 350 companies in this industry group, placing it in the top half and number 2,021 in the 5000 company Portfolio Grader company universe.
Amgen (AMGN) a Hold on Uninspiring Industry Group Rank
The current recommendation of Hold for Amgen Inc (NASDAQ:AMGN) has been derived by using Louis Navellier's methods for investing and his Portfolio Grader stock evaluator. AMGN has maintained this ranking for 2 months.
3 Big Stock Charts for Monday: Analog Devices, Inc., Amgen, Inc. and Symantec Corporation
The market continues to press higher without participation from Analog Devices, Amgen and Symantec. Stay away from these stock charts!
Earnings Growth Limit Amgen (AMGN) Rating
Amgen Inc (NASDAQ:AMGN) is ranked as a Hold using Louis Navellier's investing system and his Portfolio Grader stock evaluator. This represents no change from the previous week and is the same ranking AMGN has had from Portfolio Grader for 2 months.
Earnings Momentum Restrict Amgen (AMGN) Rating
Amgen Inc (NASDAQ:AMGN) is ranked as a Hold using the stock evaluator from Portfolio Grader, which incorporates Louis Navellier's investing system. This represents no change from the previous week and is the same ranking AMGN has had from Portfolio Grader for 2 months.
